2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives

M Guazzi, R Naeije - Journal of the American College of Cardiology, 2017 - jacc.org
Pulmonary hypertension is a common hemodynamic complication of heart failure. Interest in
left-sided pulmonary hypertension has increased remarkably in recent years because its …

JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease

C Izumi, K Eishi, K Ashihara, T Arita, Y Otsuji… - Circulation …, 2020 - jstage.jst.go.jp
The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction

G Benfari, C Antoine, WL Miller, P Thapa, Y Topilsky… - Circulation, 2019 - ahajournals.org
Background: Functional tricuspid regurgitation (FTR) is common in heart failure with reduced
ejection fraction and mostly consequent to pulmonary hypertension. However, the intrinsic …

Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society …

Authors/Task Force Members, A Vahanian… - European heart …, 2012 - academic.oup.com
After publication, dissemination of the message is of paramount importance. Pocket-sized
versions and personal digital assistant (PDA) downloadable versions are useful at the point …

Pulmonary hypertension due to left heart disease

M Guazzi, BA Borlaug - Circulation, 2012 - ahajournals.org
Pulmonary hypertension (PH) due to left heart disease, classified as group 2 according to
the Dana Point 2008 classification, is believed to be the most common cause of PH and is …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary …

JC Fang, T DeMarco, MM Givertz, BA Borlaug… - The Journal of heart and …, 2012 - Elsevier
Pulmonary hypertension associated with left heart disease is the most common form of
pulmonary hypertension encountered in clinical practice today. Although frequently a target …

Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group

J Magne, P Pibarot, PP Sengupta, E Donal… - JACC: Cardiovascular …, 2015 - jacc.org
Pulmonary hypertension (PH) is a classic pathophysiological consequence of left-sided
valvular heart disease (VHD). However, as opposed to other forms of PH, there are relatively …

Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease

M Borgarelli, J Abbott, L Braz‐Ruivo… - Journal of Veterinary …, 2015 - Wiley Online Library
Background Pulmonary hypertension (PH) is common in dogs with myxomatous mitral valve
disease (MMVD) but its effect on clinical outcome has not been investigated …